A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

OBJECTIVES: To assess the efficacy of the interleukin 1 receptor antagonist anakinra in systemic-onset juvenile idiopathic arthritis (SJIA). METHODS: A multicentre, randomised, double-blind, placebo-controlled trial was conducted. The primary objective was to compare the efficacy of a 1-month treatm...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Quartier, Pierre, Allantaz, Florence, Cimaz, Rolando, Pillet, Pascal, Messiaen, Claude, Bardin, Christophe, Bossuyt, Xavier, Boutten, Anne, Bienvenu, Jacques, Duquesne, Agnes, Richer, Olivier, Chaussabel, Damien, Mogenet, Agnes, Banchereau, Jacques, Treluyer, Jean-Marc, Landais, Paul, Pascual, Virginia
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2010
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3070271/
https://ncbi.nlm.nih.gov/pubmed/21173013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2010.134254
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados